1Dunning AM, Healey CS, pharaoh PD et al. A systematic review of genetic polymorphisms and breast cancer risk. Cancer Epidemiol biomarkers Prev, 1999, 8:843-854.
2Spurdle AB, Hopper JL, Dite Gs et al. CYPD promoter polymorphism and breast cancer in Australian women under age forty years. J Natl Cancer lnst, 2000, 18 (20): 1674 N1681.
3Sasano H, Ozaki M Aromatase expressing and its Localization in human breast cancer. J Steroid Biochem Mol Bid, 1997, 61 (3) : 29.
4Yager JD Lieher JG. Molecular mechanisms of estrogen carcinogenesis . Annu Rev Pharmacol Toxicol, 1996, 36 : 203 - 232.
5Byers T, Graham S, Rzepka T et al. Lactation and breast cancer. Am JEpidemiol, 1985, 121:664.
6Hieken T J, Harrison J, Herreros J et al. Correlating sonography, mammography , and pathology in the assessment of breast cancer size. Am Jsury, 2001, 182 (4) : 351.
7Cosgrave Do, Bamber JC, Davey JB et al. Color Doppler Signals from breast tumors: work in progress. Radiology, 1990, 176:175.
8Friendrich MC, Sickles EA. Radiological Dghosis of breast diseases. Heidelberg: springer - verlag, 1997 : 261.
9蒋树娟.乳头溢液细胞学检查与病理改变的关系[J].中国临床细胞杂志,1988,3:55-55.
10Developed and approved at National Cancer Institude- Sponsored Conference. The unifoem approach to breast fine needle aspiration biopsy.Acta Cytol, 1996, 40:1120 - 1126.
